Balance Sheet

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 76 $ 6,776
Other current assets 288 255
Total current assets 364 7,031
Property and equipment, net 97 0
In-process research and development acquired 15,000 15,000
Intangible assets, net 5,155 6,477
Other assets 100 100
Total assets 20,716 28,608
Current liabilities    
Accounts payable 5,535 3,569
Accrued expenses 1,679 2,120
Advances from related parties 186 266
Notes and loans payable, current portion, net of debt discount 7,462 3,296
Total current liabilities 14,862 9,251
Notes and loans payable, net of current portion 870 1,457
Deferred tax liability 4,142 4,142
Total liabilities 19,874 14,850
Commitments and contingencies (Note 12)
Stockholders' Equity    
Series E Preferred Stock, net of discount, par value $0.0001, 18,000 shares authorized, 3,713 and 12,191 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively 0 0
Common stock, $0.0001 par value; authorized 225,000,000 shares; 44,964,491 and 21,002,212 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively 4 2
Additional paid-in capital 127,607 127,292
Accumulated deficit (126,769) (113,536)
Total stockholders' equity 842 13,758
Total liabilities and stockholders' equity $ 20,716 $ 28,608

Source